PUBLISHER: The Business Research Company | PRODUCT CODE: 1948370
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948370
Tumor ablation is a minimally invasive medical procedure designed to eliminate cancerous tissues by applying extreme heat, cold, or chemical agents directly to the tumor, causing cell death. This approach is commonly used for treating small tumors or those located in challenging anatomical locations.
The primary types of tumor ablation include thermal ablation and chemical ablation. Thermal ablation involves using extreme heat to destroy abnormal or diseased tissue, and it is employed across various treatments such as percutaneous, laparoscopic, and surgical procedures for conditions such as kidney cancer, liver cancer, breast cancer, lung cancer, prostate cancer, among others. End users of these techniques include hospitals, oncology centers, and other healthcare facilities.
Tariffs are impacting the tumor ablation market by increasing costs of imported ablation probes, generators, imaging guidance systems, and precision electronic components. Oncology centers in North America and Europe are most affected due to reliance on imported high-end medical devices, while Asia-Pacific faces cost pressures on export-oriented manufacturing. These tariffs are increasing procedural equipment costs and slowing technology adoption. However, they are also encouraging domestic device production, localized component sourcing, and innovation in cost-efficient ablation systems.
The tumor ablation market research report is one of a series of new reports from The Business Research Company that provides tumor ablation market statistics, including tumor ablation industry global market size, regional shares, competitors with a tumor ablation market share, detailed tumor ablation market segments, market trends and opportunities, and any further data you may need to thrive in the tumor ablation industry. This tumor ablation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The tumor ablation market size has grown rapidly in recent years. It will grow from $1.62 billion in 2025 to $1.81 billion in 2026 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to growing incidence of solid tumors, increased adoption of minimally invasive cancer treatments, expansion of oncology care centers, availability of advanced imaging guidance, improved clinical outcomes of ablation therapies.
The tumor ablation market size is expected to see rapid growth in the next few years. It will grow to $2.69 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing demand for targeted cancer therapies, rising investments in precision oncology solutions, expansion of outpatient cancer treatment facilities, integration of ai-based treatment planning, growing focus on patient-centric cancer care. Major trends in the forecast period include increasing adoption of minimally invasive ablation procedures, rising use of image-guided ablation technologies, growing preference for thermal ablation techniques, expansion of outpatient tumor treatment settings, enhanced focus on precision oncology.
The rising adoption of minimally invasive procedures is expected to drive the growth of the tumor ablation market going forward. Minimally invasive interventions, including robot-assisted surgeries, involve surgical techniques that use small or no incisions to reduce recovery time, minimize complications, and lower postoperative pain. This trend is fueled by growing patient demand for faster recovery, advancements in surgical robotics, and improved imaging-guided treatment accuracy. Tumor ablation technologies-such as radiofrequency, microwave, and cryoablation-support this shift by enabling precise destruction of cancerous tissue while preserving surrounding healthy structures. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures increased by 7% in 2023, outpacing the growth rate of surgical procedures by 2%. Hand surgeries such as carpal tunnel, arthritis, and trigger finger totaled 207,887 procedures, a 2% rise from 2022. Therefore, the increasing use of minimally invasive procedures is driving the growth of the tumor ablation market.
Major companies in the tumor ablation market are focusing on developing advanced solutions, such as bone tumor ablation systems, to improve treatment precision, enhance patient outcomes, and broaden the spectrum of treatable tumors. A bone tumor ablation system is a specialized device designed for minimally invasive treatment of bone tumors. For instance, in March 2024, Medtronic plc, an Ireland-based medical device company, received U.S. Food and Drug Administration (FDA) 510(k) clearance for its OsteoCool 2.0 bone tumor ablation system. The upgraded system is intended for treating painful bone metastases and benign bone tumors, including osteoid osteoma. OsteoCool 2.0 allows simultaneous use of four internally cooled probes, enabling ablation of two vertebral bodies at once or creating larger ablation zones in extra-spinal applications. The system delivers 20W per channel, more than double the power of the Stryker OptaBlate bone tumor ablation system.
In August 2025, K5 Global, a US-based growth-focused technology investment firm, acquired HistoSonics Inc. for $2.25 billion. Through this acquisition, K5 Global aims to accelerate the global commercialization of HistoSonics' non-invasive tumor-ablation platform and expand its clinical and regulatory presence. HistoSonics is a US-based healthcare technology company that develops the Edison histotripsy system, a focused-ultrasound solution for non-invasive soft-tissue tumor ablation.
Major companies operating in the tumor ablation market are Medtronic plc, Siemens Healthineers AG, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Varian Medical Systems Inc., Merit Medical Systems Inc., Accuray Incorporated, AngioDynamics Inc., EDAP TMS S.A., NeuWave Medical Inc., Mirabilis Medical Inc., STARMed Co. Ltd., Profound Medical Corp., RF Medical Co. Ltd., IceCure Medical Ltd., MedWaves Inc., Chongqing Haifu Medical Technology Co. Ltd., Hologic Inc., Johnson & Johnson MedTech
North America was the largest region in the tumor ablation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor ablation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the tumor ablation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The tumor ablation market includes revenues earned by entities by providing services such as consultation, diagnosis, chemical ablation, and post-procedure care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Tumor Ablation Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses tumor ablation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for tumor ablation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tumor ablation market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.